title: Is the current use of 'positivity' thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints?
authors.forename: Laura
authors.initials: L
authors.lastname: Richert
authors.forename: Rodolphe
authors.initials: R
authors.lastname: Thiebaut
mesh_terms: D016915:AIDS Vaccines / Q000276:immunology*; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D019562:Viral Load
chemical_list: D016915:AIDS Vaccines